Anti-Osteoclast Therapy as Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
Clinical trial NCT03173976 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03173976
- Sponsor
- Mohammed Milhem
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-18
- Primary completion
- 2023-04-20
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.